Skip to Content
MilliporeSigma
HomeWestern BlottingesiRNA Knockdown Efficiency Tested by Western Blotting

esiRNA Knockdown Efficiency Tested by Western Blotting

A valuable measure of the knock-down potency of any RNAi experiment is the reduction in protein level. Displayed below are the knock-down rates of  selected esiRNAs using quantitative western blot analysis (Odyssey, Li-COR). The time point for maximum knock-down rate for each protein can vary significantly, as it is depending on factors such as protein stability, turn-over rate or cell proliferation rates. The knock-down validation on protein level was performed at 72 hours post transfection of esiRNA in HeLa cells. To be able to assess knock-down rates, the expression levels of the protein of interest was compared to HeLa cells simultaneously transfected with Renilla Luciferase (negative control). Specific antibodies for the protein of interest were used for the quantitative western blot analysis.

Quantitative Western Blotting

Western blot analyses 72 hours after transfection of HeLa cells with the indicated esiRNAs. Lane 1 contains, a negative control, HeLa cells transfected with Renilla Luciferase esiRNA. Lane 2 includes HeLa cells transfected with the indicated esiRNA. Lysates were separated on SDS-PAGE and probed with the indicated primary antibody. For lanes 1 and 2, the individual esiRNA targets are shown in green while the loading controls are in red. The signal intensities were quantified using an Odyssey infrared imaging system (LI-COR) and normalized to the loading control signal (GAPDH or tubulin).

 
   AKT1OCT4BCL2
 
esiRNAEHU083501EMU081351EHU135281
AntibodyP2482-.2MLP0082-200UL   B3170-.2ML

         CAT  
     HSP90           PLK1
esiRNA        EHU048671      EHU114671         EHU051011
Antibody        C0979-.2ML     H1775-.2ML        P5998-200UL

         CAV1            CDK4        ABL1
esiRNA         EHU031251        EHU070511       EHU141291
Antibody        SAB4200216        C8218-.5ML       A5844-.2ML

          FAS
         VCL
          CAPN1
esiRNA         EHU060231         EHU088101         EHU032581
Antibody           F4424-.1ML         SAB4200080-200UL         C267-100UL

         KRAS        PTEN 
esiRNA        EHU114431        EHU106441 
Antibody        R3400-.1MG        P3487

The reduction in target expression was measured between the negative control RLUC and the sample treated with esiRNA as indicated.

Materials
Sorry, an unexpected error has occurred

Network error: Failed to fetch

Sign In To Continue

To continue reading please sign in or create an account.

Don't Have An Account?